Leilei Huang

Identification of isotschimgine as a novel farnesoid X receptor agonist with potency for the treatment of obesity in mice.

Shengjie Fan, Cheng Huang, Zunli Ke, 2020, Biochemical and biophysical research communications.

Isotschimgine alleviates nonalcoholic steatohepatitis and fibrosis via FXR agonism in mice

Peiyong Zheng, Shengjie Fan, Cheng Huang, 2021, Phytotherapy research : PTR.

Ecust004 Suppresses Breast Cancer Cell Growth, Invasion, and Migration via EMT Regulation

Xin Hu, Fan-hong Wu, Liwei Sun, 2021, Drug design, development and therapy.

Typing the tumor immune signatures in patients of Lynch syndrome facilitates predicting the responsiveness of immune checkpoint inhibition

Yihang Pan, G. Zheng, Changhua Zhang, 2022 .

DDDT_A_309132 3451..3461

F. Wu, Leilei Huang, Hui-Jun Nie, 2021 .

Design, synthesis and biological evaluation of combretastatin A-4 sulfamate derivatives as potential anti-cancer agents.

Y. Li, Fan-hong Wu, Jinwen Huang, 2021, RSC medicinal chemistry.

Immune desert in MMR-deficient tumors predicts poor responsiveness of immune checkpoint inhibition

Yan Li, Yihang Pan, G. Zheng, 2023, Frontiers in Immunology.